QQ客服 官方微博 反馈留言

	CRISPR/Cas9-mediated PD-1 disruption enhances human mesothelin-targeted CAR T cell effector functions
	Zi, Zhenguo; Jin, Yanling; Li, Gaoxin; Shao, Kang; Cai, Qiliang; Hu, Wanghong; Ma, Xiaojing; Wei, Fang
刊名	CANCER IMMUNOLOGY IMMUNOTHERAPY
	2019
卷号	68期号:3
关键词	Mesothelin Chimeric antigen receptor Programmed cell death protein 1 SgRNA-guided clustered regularly interspaced short palindrome repeats-associated nuclease Cas9
ISSN号	0340-7004
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3595776
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Zi, Zhenguo,Jin, Yanling,Li, Gaoxin,et al. CRISPR/Cas9-mediated PD-1 disruption enhances human mesothelin-targeted CAR T cell effector functions[J]. CANCER IMMUNOLOGY IMMUNOTHERAPY,2019,68(3).
APA	Zi, Zhenguo.,Jin, Yanling.,Li, Gaoxin.,Shao, Kang.,Cai, Qiliang.,...&Wei, Fang.(2019).CRISPR/Cas9-mediated PD-1 disruption enhances human mesothelin-targeted CAR T cell effector functions.CANCER IMMUNOLOGY IMMUNOTHERAPY,68(3).
MLA	Zi, Zhenguo,et al."CRISPR/Cas9-mediated PD-1 disruption enhances human mesothelin-targeted CAR T cell effector functions".CANCER IMMUNOLOGY IMMUNOTHERAPY 68.3(2019).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。